Last reviewed · How we verify

Dexamethasone / Prednisolone — Competitive Intelligence Brief

Dexamethasone / Prednisolone (Dexamethasone / Prednisolone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Corticosteroid (glucocorticoid). Area: Immunology, Rheumatology, Oncology (supportive care), Endocrinology.

marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR) Immunology, Rheumatology, Oncology (supportive care), Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

Dexamethasone / Prednisolone (Dexamethasone / Prednisolone) — Johann Wolfgang Goethe University Hospital. Dexamethasone and prednisolone are corticosteroids that suppress the immune system and reduce inflammation by binding to glucocorticoid receptors and inhibiting pro-inflammatory cytokine production.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Dexamethasone / Prednisolone TARGET Dexamethasone / Prednisolone Johann Wolfgang Goethe University Hospital marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Methyl Prednisolonate Methyl Prednisolonate Ain Shams University marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
prednison, Azenil prednison, Azenil Tel-Aviv Sourasky Medical Center marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)
Depo-Medrol Depo-Medrol Hamilton Health Sciences Corporation marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
every week IVMP therapy every week IVMP therapy Medical University of Warsaw marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
Local steroid - triamcinolone acetonide Local steroid - triamcinolone acetonide Instituto do Cancer do Estado de São Paulo marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor
standard prednisolone treatment standard prednisolone treatment Institute of Child Health marketed Corticosteroid (glucocorticoid) Glucocorticoid receptor (GR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Corticosteroid (glucocorticoid) class)

  1. Assistance Publique - Hôpitaux de Paris · 3 drugs in this class
  2. Astellas Pharma Inc · 2 drugs in this class
  3. Sanofi · 2 drugs in this class
  4. Xinqiao Hospital of Chongqing · 2 drugs in this class
  5. Berinstein, Jeffrey · 2 drugs in this class
  6. Ain Shams University · 2 drugs in this class
  7. Children's Hospital of Philadelphia · 1 drug in this class
  8. Celgene · 1 drug in this class
  9. Hamilton Health Sciences Corporation · 1 drug in this class
  10. Erasme University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dexamethasone / Prednisolone — Competitive Intelligence Brief. https://druglandscape.com/ci/dexamethasone-prednisolone. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing